Company intelligence / Profile preview

UDC Ventures

Ewing, New Jersey, United States

Ownership: Private
Development stage: Other

Overview

UDC Ventures is the corporate venture capital arm of Universal Display, launched in 2019 to invest in disruptive and emerging technology companies. Its investment focus spans display technologies, organic and printed electronics, sustainability solutions, artificial intelligence, hardtech, and selected biotech, pharma, and life sciences opportunities. The firm is not itself a drug developer, healthcare operator, or therapeutic company; rather, it acts as a strategic investor seeking partnerships with entrepreneurs and start-ups. For biotech analysts, UDC Ventures is best understood as a cross-sector corporate VC with some life sciences interest, not as a dedicated biopharma company with an internal therapeutic pipeline.

Industry: Investors

Beyond the preview

Go deeper on UDC Ventures.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on UDC Ventures.

Explore the full profile